Growth Metrics

Sarepta Therapeutics (SRPT) Prepaid Assets (2016 - 2025)

Sarepta Therapeutics has reported Prepaid Assets over the past 16 years, most recently at $171.9 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 89.98% year-over-year to $171.9 million; the TTM value through Dec 2025 reached $171.9 million, up 89.98%, while the annual FY2025 figure was $171.9 million, 89.98% up from the prior year.
  • Prepaid Assets for Q4 2025 was $171.9 million at Sarepta Therapeutics, down from $192.3 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $192.3 million in Q3 2025 and troughed at $376000.0 in Q1 2022.
  • A 5-year average of $108.6 million and a median of $130.0 million in 2022 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: plummeted 99.79% in 2022 and later surged 47710.9% in 2023.
  • Year by year, Prepaid Assets stood at $149.0 million in 2021, then crashed by 97.51% to $3.7 million in 2022, then skyrocketed by 1990.77% to $77.7 million in 2023, then increased by 16.4% to $90.5 million in 2024, then surged by 89.98% to $171.9 million in 2025.
  • Business Quant data shows Prepaid Assets for SRPT at $171.9 million in Q4 2025, $192.3 million in Q3 2025, and $4.1 million in Q2 2025.